Hepatic Angiosarcoma is a rare, high grade, aggressive mesenchymal tumor. It is the most common malignant mesenchymal tumor of the liver, but is nonetheless rare, accounting for 2% of all primary liver malignancies, with a male predominance. Some hepatic Angiosarcoma were associated with exposure to anabolic steroids, radiation, thorium dioxide, arsenic, vinyl chloride and use of oral contraceptives, but most cases are now considered idiopathic. Given that hepatic angiosarcoma clinical, laboratory and radiologic presentation are non specific, radical resection of the tumor is being currently the best treatment option. Its diagnosis is difficult and often delayed, and requires histopathological examination. The prognosis is extremely poor with a high mortality rate and few therapeutic options. We report a case of a woman who presented with acute liver failure, which is a very unusual presentation of HAS, diagnosed with hepatic angiosarcoma through a liver biopsy. She had a rapidly worsening clinical course and died within four months of diagnosis.
Background
HAS is a rare and aggressive mesenchymal tumor associated with rapid liver failure and high mortality rate. It was associated with environmental exposure to carcinogens but etiology still unknown in the majority of the cases.
Given the non specific symptoms and variable imaging findings, diagnosis is difficult and often delayed, requiring careful Histopathological examination. It carries a grim prognosis even with treatment, including surgical resection.
We report a case of primary Angiosarcoma of the liver, which presented with acute liver failure, which is an uncommon presentation of a primary liver tumor. This case highlights the need to consider the diagnosis of hepatic Angiosarcoma as a differential in front of acute liver failure presentation without any clear etiology. 
Case Report

Discussion
Hepatic angiosarcoma is a rare, non cirrhotic, agressive tumour of endothelial cell origin that line the walls of blood vessels. Its accounting for 2% of primary liver malignancy and it remains the third most common primary hepatic malignant tumour and fifth most common sites for angiosarcomas [ metastases or primary liver tumour [6] . In HAS, the mechanism of liver failure is multifactorial. It is suggested that it be related to ischemia of the hepatic parenchyma, tumour thrombi due to portal vein occlusion and non occlusive infarction of liver due to sepsis or cardiac shock and the replacement of the hepatocytes by malignant cells that lead to secondary necrosis [7, 8] . From a radiologic point of view, currently there are no known pathognomonic features for HAS and it is difficult to distinguish HAS from other primary liver tumors due to the various morphologic appearances [3, 9] . CT and MRI both participate in the diagnosis by showing the hypervascular and heterogeneous character of HAS [10] [11] [12] .
The final diagnosis is made with a histologic examination.
However, the vascular nature of the tumor makes it difficult to perform the biopsy, exposing to increased risk of hemorrhage [13] . Otherwise, the risk of false-negative biopsies remain also a problem due to a high frequency of haemorragic and necrotic foci within the tumour [14] .
Microscopically, it is characterized by four patterns: cytokeratin, FLI-1,6 D2-40, and Ki-67 [17, 18] . Make a differential diagnosis with benign tumor is important to do.
In fact, tumor cells may also form their own disorganized anastomotic vascular channels, shape solid nodules or nests, 
Conclusion
HAS is an infrequent tumor in female patients, and acute liver failure is a very rare presentation of this disease. This unusual combination of clinical characteristics was part of the case we reported. Our patient had a progressively worsening clinical course and died within four months of diagnosis. This demonstrates the rapid progression, poor prognosis, and the need to find a therapy that improves survival. In the absence of a clear etiology for acute liver failure, primary liver tumor must be considered in the differential diagnosis and a biopsy should be arranged to reach definitive diagnosis. A diagnosis made soon, will make a difference in the treatment options, outcome and prognosis of these patients.
